Cipla Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹1418.70
Market cap
1,14,537 Cr
Stock P/E
35.3
P/B
3.32
Dividend yield
1.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales6,329 Cr6,678 Cr6,604 Cr6,163 Cr6,694 Cr7,051 Cr7,073 Cr6,730 Cr6,957 Cr7,589 Cr7,074 Cr6,541 Cr
Operating expenses (approx.)4,835 Cr4,944 Cr4,856 Cr4,847 Cr4,978 Cr5,165 Cr5,084 Cr5,192 Cr5,179 Cr5,695 Cr5,819 Cr5,586 Cr
EBITDA1,494 Cr1,734 Cr1,748 Cr1,316 Cr1,716 Cr1,886 Cr1,989 Cr1,538 Cr1,778 Cr1,895 Cr1,255 Cr955 Cr
OPM %23.6%26.0%26.5%21.4%25.6%26.7%28.1%22.8%25.6%25.0%17.7%14.6%
Other income136 Cr176 Cr185 Cr249 Cr160 Cr191 Cr222 Cr289 Cr259 Cr269 Cr206 Cr148 Cr
Interest16 Cr26 Cr30 Cr18 Cr18 Cr15 Cr15 Cr14 Cr14 Cr13 Cr14 Cr13 Cr
Depreciation239 Cr290 Cr233 Cr288 Cr247 Cr272 Cr280 Cr309 Cr253 Cr297 Cr278 Cr383 Cr
Profit before tax1,375 Cr1,594 Cr1,474 Cr1,259 Cr1,611 Cr1,789 Cr1,916 Cr1,504 Cr1,770 Cr1,854 Cr893 Cr707 Cr
Tax %27.5%27.5%27.5%25.8%27.0%27.0%17.3%18.6%27.0%27.0%24.5%22.2%
Net profit998 Cr1,155 Cr1,068 Cr932 Cr1,175 Cr1,305 Cr1,575 Cr1,214 Cr1,292 Cr1,353 Cr674 Cr543 Cr
EPS (₹)₹12.34₹14.01₹13.08₹11.63₹14.58₹16.13₹19.45₹15.13₹16.07₹16.73₹8.37₹6.87

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales16,362 Cr17,132 Cr19,160 Cr21,763 Cr22,753 Cr25,774 Cr27,548 Cr28,163 CrSign in for TTM
Operating expenses (approx.)13,265 Cr13,926 Cr14,907 Cr17,211 Cr17,726 Cr19,483 Cr20,420 Cr22,280 CrSign in for TTM
EBITDA3,097 Cr3,206 Cr4,252 Cr4,553 Cr5,027 Cr6,291 Cr7,128 Cr5,883 CrSign in for TTM
OPM %18.9%18.7%22.2%20.9%22.1%24.4%25.9%20.9%Sign in for TTM
Other income477 Cr344 Cr266 Cr281 Cr475 Cr747 Cr862 Cr882 CrSign in for TTM
Interest168 Cr197 Cr161 Cr106 Cr110 Cr90 Cr62 Cr54 CrSign in for TTM
Depreciation1,326 Cr1,175 Cr1,068 Cr1,052 Cr1,172 Cr1,051 Cr1,107 Cr1,211 CrSign in for TTM
Profit before tax2,079 Cr2,178 Cr3,290 Cr3,493 Cr4,038 Cr5,702 Cr6,821 Cr5,224 CrSign in for TTM
Tax %27.4%29.0%27.0%26.7%29.8%27.1%22.4%25.9%Sign in for TTM
Net profit1,492 Cr1,500 Cr2,389 Cr2,547 Cr2,833 Cr4,154 Cr5,269 Cr3,862 CrSign in for TTM
EPS (₹)₹18.97₹19.19₹29.82₹31.20₹34.72₹51.05₹65.29₹48.03Sign in for TTM
Dividend payout %———15.8%14.2%16.5%19.9%33.5%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital161 Cr161 Cr161 Cr161 Cr161 Cr161 Cr162 Cr162 Cr
Reserves14,851 Cr15,602 Cr18,165 Cr20,680 Cr23,246 Cr26,545 Cr31,032 Cr34,270 Cr
Borrowings————520 Cr247 Cr92 Cr258 Cr
Other liabilities————5,229 Cr5,668 Cr6,006 Cr7,718 Cr
Total liabilities————29,463 Cr32,718 Cr37,387 Cr42,496 Cr
Fixed assets (net)————4,991 Cr5,069 Cr5,262 Cr6,040 Cr
CWIP————689 Cr864 Cr1,213 Cr1,586 Cr
Investments————3,662 Cr5,449 Cr7,933 Cr8,223 Cr
Other assets————16,813 Cr19,393 Cr23,265 Cr24,169 Cr
Total assets————29,463 Cr32,718 Cr37,387 Cr42,496 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———3,326 Cr3,238 Cr4,134 Cr5,005 Cr3,940 Cr
Cash from investing———-1,872 Cr-2,389 Cr-2,988 Cr-3,691 Cr-2,326 Cr
Cash from financing———-1,600 Cr-958 Cr-1,200 Cr-1,293 Cr-1,234 Cr
Net cash flow———-146 Cr-109 Cr-55 Cr21 Cr380 Cr
Free cash flow (OCF − Capex)———2,782 Cr2,397 Cr3,036 Cr3,843 Cr2,341 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.8%12.9%17.4%16.8%15.9%19.4%19.2%13.4%
ROE %10.2%9.8%13.1%12.1%11.8%15.4%16.9%11.2%
Debtor days————65687373
Inventory days————340366380411
Days payable————162173191201
Cash conversion cycle————243261261282
Debt / equity————0.020.00920.00300.0075
Current ratio————3.343.704.243.44
Net debt / EBITDA0.000.000.000.00-0.02-0.06-0.07-0.13

Compare with peers

Loading peers…